Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carsten Schürfeld"'
Autor:
Florian J. Wopperer, Karl X. Knaup, Kira J. Stanzick, Karen Schneider, Tilman Jobst-Schwan, Arif B. Ekici, Steffen Uebe, Andrea Wenzel, Stefan Schliep, Carsten Schürfeld, Randolf Seitz, Wanja Bernhardt, Markus Gödel, Antje Wiesener, Bernt Popp, Klaus J. Stark, Hermann-Josef Gröne, Björn Friedrich, Martin Weiß, Nikolina Basic-Jukic, Mario Schiffer, Bernd Schröppel, Bruno Huettel, Bodo B. Beck, John A. Sayer, Christine Ziegler, Maike Büttner-Herold, Kerstin Amann, Iris M. Heid, André Reis, Francesca Pasutto, Michael S. Wiesener
Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) is caused by mutations in one of at least five genes and leads to kidney failure usually in mid adulthood. Throughout the literature, variable numbers of families have been reported, where
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2575f0e83adf0d5a5ddc111d91231443
Autor:
Holger Stein, Carsten Schürfeld, Tobias A Marsen, Juergen R. Schaefer, Günter Klaus, Christina Taylan, Lars Pape, Matthias Galiano, Jens König, Joenna Driemeyer, Jun Oh, Andreas Heibges, Lutz T. Weber, Reinhard Klingel, Michael Koziolek, Ralf Spitthöver, Axel Versen, Rainer Büscher, Claus Peter Schmitt
Publikováno v:
The American journal of cardiology. 136
Twenty-four patients with bi-allelic familial hypercholesterolemia commencing chronic lipoprotein apheresis (LA) at a mean age of 8.5 ± 3.1 years were analysed retrospectively and in part prospectively with a mean follow-up of 17.2 ± 5.6 years. Mea
Autor:
Jun Oh, Carsten Schürfeld, Joenna Driemeyer, Claus Peter Schmitt, Andreas Heibges, Juergen R. Schaefer, Günter Klaus, Matthias Galiano, Christina Taylan, Lutz T. Weber, Ralf Spitthöver, Reinhard Klingel, Jens König, Lars Pape, Rainer Büscher
Publikováno v:
Pediatric Nephrology. 33:1199-1208
Familial hypercholesterolemia (FH) causes premature cardiovascular disease (CVD). Lipoprotein apheresis (LA) is recommended as first-line lipid-lowering treatment (LLT) for homozygous (ho) FH. Efficacy of multimodal LLT including lifestyle counseling
Publikováno v:
CardioVasc. 18:32-34
Autor:
Franz Heigl, Markus Ketteler, Andrea Raabe, Reinhard Klingel, Michael Moesenthin, Volker Schettler, Wanja M. Bernhardt, Ulrich Julius, Ralf Kühn, Markus Knittel, Andreas Heibges, Josef Leebmann, Tilmann Röseler, Ralf Spitthöver, Eberhard Röseler, Carsten Schürfeld
Publikováno v:
Journal of clinical apheresis. 34(4)
INTRODUCTION Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with monoclonal antibodies has complemented the armamentarium of lipid-lowering therapy (LLT) before the final step of commencing chronic lipoprotein apheresis (LA). Data a
Publikováno v:
Journal of clinical lipidology. 12(4)
Xanthomas are visibly deforming cholesterol deposits that develop after long-term exposure to high serum low-density lipoprotein cholesterol concentrations. We present the case of a 10-year-old boy suffering from homozygous familial hypercholesterole